PT  - JOURNAL ARTICLE
AU  - Sean O’Donnell
TI  - Proceedings of the 2019 Viral Clearance Symposium: Introduction
AID  - 10.5731/pdajpst.2021.012676
DP  - 2022 Jul 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - 295--296
VI  - 76
IP  - 4
4099  - http://journal.pda.org/content/76/4/295.short
4100  - http://journal.pda.org/content/76/4/295.full
SO  - PDA J Pharm Sci Technol2022 Jul 01; 76
AB  - This article introduces the presentations from the 2019 Viral Clearance Symposium, which was held in Claremont, California. The Viral Clearance Symposium contained regulatory perspectives presented by representative from the Paul-Ehrlich-Institute, United States Food and Drug Administration, and Health Canada. Industry members presented on several areas related to viral safety including viral clearance strategies for manufacturing processes, continuous processing, upstream and facility risk mitigation, and virus detection methods.